Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma

BACKGROUND: Several potential predictive markers of efficacy of targeted agents in patients with metastatic renal cell carcinoma (mRCC) have been identified. Interindividual heterogeneity warrants further investigation. PATIENTS AND METHODS: Multicenter, observational, retrospective study in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Puente, Javier, Laínez, Nuria, Dueñas, Marta, Méndez-Vidal, María José, Esteban, Emilio, Castellano, Daniel, Martinez-Fernández, Mónica, Basterretxea, Laura, Juan-Fita, María José, Antón, Luis, León, Luis, Lambea, Julio, Pérez-Valderrama, Begoña, Vázquez, Sergio, Suarez, Cristina, del Muro, Xavier Garcia, Gallardo, Enrique, Maroto, José Pablo, Samaniego, M Luz, Suárez-Paniagua, Beatriz, Sanz, Julián, Paramio, Jesús M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444752/
https://www.ncbi.nlm.nih.gov/pubmed/28423742
http://dx.doi.org/10.18632/oncotarget.16494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444752/
https://www.ncbi.nlm.nih.gov/pubmed/28423742
http://dx.doi.org/10.18632/oncotarget.16494

Ejemplares similares